Steven Daveluy, MD
Dermatology · Dearborn, MINPI 1467611475
Payments from drug & device makers
Across 904 payments — averaging $762.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$153K
- UCB, Inc.$139K
- Pfizer$126K
- AbbVie$113K
- Regeneron$70K
- Novartis$39K
- plus $49K from 43 others
Across 1 payment — averaging $713.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$713
What the payments were for
- Consulting fees$130,41037%
- Speaking & faculty fees$166,97648%
- Travel & lodging$31,6399%
- Food & beverage$20,8286%
- Education$2260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$688,880 in reported general payments places this provider in the 95th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 25 | $334,714 |
| Cosentyx Unoready PenSecukinumab | 14 | $135,424 |
| Dupixent PenDupilumab | 28 | $106,988 |
| Taltz AutoinjectorIxekizumab | 13 | $85,309 |
| ValchlorMechlorethamine Hcl | 11 | $69,494 |
| Imiquimod | 27 | $14,972 |
| Timolol Maleate | 14 | $12,352 |
| Clobetasol Propionate | 183 | $6,771 |
| Triamcinolone Acetonide | 146 | $2,416 |
| Ketoconazole | 105 | $1,729 |
| Betamethasone Dipropionate | 25 | $1,637 |
| Ammonium Lactate | 43 | $1,049 |
| Clindamycin Phosphate | 28 | $629 |
| Doxycycline Monohydrate | 19 | $364 |
| Hydrocortisone | 36 | $111 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dearborn
- Michael GoldfarbDearborn$532K
- Johann GudjonssonAnn Arbor$15.9M
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
- Brent BoyceSebewaing$2.2M
- David AltmanWarren$1.9M
- Christofer BuattiAuburn Hills$1.6M
- Mio NakamuraAnn Arbor$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.